A randomized controlled trial of opt-in versus opt-out colorectal cancer screening outreach

American Journal of Gastroenterology

Volumn 113, Issue 12, 2018, Pages 1848-1854

  Mehta, Shivan J ^a,b   Khan, Tanya ^a,b   Guerra, Carmen ^a   Reitz, Catherine ^a,b   McAuliffe, Timothy ^a,b   Volpp, Kevin G ^a,b,c   Asch, David A ^a,b,c   Doubeni, Chyke A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT PARTICIPATION; POSTAL MAIL; PRAGMATIC TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; IMMUNOLOGICAL PROCEDURES; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; REFUSAL TO PARTICIPATE; STATISTICS AND NUMERICAL DATA;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; REFUSAL TO PARTICIPATE;

EID: 85048707360     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/s41395-018-0151-3     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095-105.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71.
4. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-57.
5. Joseph DA, King JB, Miller JW, et al. Prevalence of colorectal cancer screening among adults-Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Suppl. 2012;61:51-6.
6. USPST Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564-75.
7. White A, Thompson TD, White MC, et al. Cancer screening test use -United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201-6.
8. Halm EA, Beaber EF, McLerran D, et al. Association between primary care visits and colorectal cancer screening outcomes in the era of population health outreach. J Gen Intern Med. 2016;31:1190-7.
9. Levin TR, Jamieson L, Burley DA, et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33: 101-10.
10. Mehta SJ, Jensen CD, Quinn VP, et al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med. 2016;31: 1323-30.
11. Green BB, Wang C, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: A randomized trial. Ann Intern Med. 2013;158:301-11.
12. Sequist TD, Zaslavsky AM, Colditz GA, et al. Electronic patient messages to promote colorectal cancer screening: A randomized, controlled trial. Arch Intern Med. 2011;171:636-41.
13. Charters TJ, Strumpf EC, Sewitch MJ. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians. BMC Health Serv Res. 2013;13:449.
14. Klabunde C, Blom J, Bulliard J-L, et al. Participation rates for organized colorectal cancer screening programmes: An international comparison. J Med Screen. 2015;22:119-26.
15. Daly JM, Levy BT, Merchant ML, et al. Mailed fecal-immunochemical test for colon cancer screening. J Community Health. 2010;35:235-9.
16. Wilson FA, Villarreal R, Stimpson JP, et al. Cost-effectiveness analysis of a colonoscopy screening navigator program designed for Hispanic men. J Cancer Educ. 2015;30:260-7.
17. Elkin EB, Shapiro E, Snow JG, et al. The economic impact of a patient navigator program to increase screening colonoscopy. Cancer. 2012;118:5982-8.
18. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: A randomized clinical trial. JAMA Intern Med. 2013;173:1725-32.
19. Singal AG, Gupta S, Skinner CS, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: A randomized clinical trial. JAMA. 2017;318:806-15.
20. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211:453-8.
21. Mehta SJ, Asch DA. How to help gastroenterology patients help themselves: Leveraging insights from behavioral economics. Clin Gastroenterol Hepatol. 2014;12:711-4.
22. Kahneman D, Tversky A. Prospect theory: An analysis of decision under risk. Econometrica. 1979;47:263-91.
23. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298:2415-7.
24. O'Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89:103-24.
25. Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertain. 1988;1:7-59.
26. Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. New Engl J Med. 2007;357:1340-4.
27. Chapman GB, Li M, Colby H, et al. Opting in vs opting out of influenza vaccination. JAMA. 2010;304:43-44.
28. Johnson EJ, Goldstein D. Do defaults save lives? Science. 2003;302: 1338-9.
29. Mehta SJ, Troxel AB, Marcus N, et al. Participation rates with opt-out enrollment in a remote monitoring intervention for patients with myocardial infarction. JAMA Cardiol. 2016;1:847-8.
30. Yudin MH, Moravac C, Shah RR. Influence of an "opt-out" test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol. 2007;110:81-6.
31. Aysola J, Tahirovic E, Troxel AB, et al. A randomized controlled trial of opt-in versus opt-out enrollment into a diabetes behavioral intervention. Am J Health Promot. 2016;32:745-52.
32. Schwartz J, Mochon D, Wyper L, et al. Healthier by precommitment. Psychol Sci. 2014;25:538-46.
33. Milkman KL, Beshears J, Choi JJ, et al. Using implementation intentions prompts to enhance influenza vaccination rates. Proc Natl Acad Sci USA. 2011;108:10415-20.
34. Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent -impediments to health care innovation. N Engl J Med. 2017;377: 1412-4.
35. U.S. Census Bureau. Social Explorer [database online]. Social Explorer, Bronxville, NY. 2015. https://www.socialexplorer.com/tables/ ACS2015_5yr/R11471487. Accessed 28 Sep 2017.
36. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110:2083-91.
37. Charlton ME, Mengeling MA, Halfdanarson TR, et al. Evaluation of a home-based colorectal cancer screening intervention in a rural state. J Rural Health. 2014;30:322-32.
38. Myers RE, Ross EA, Wolf TA, et al. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care. 1991;29:1039-50.
39. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770-80.
40. Goldman SN, Liss DT, Brown T, et al. Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in community health centers: A randomized controlled trial. J Gen Intern Med. 2015;30:1178-84.
41. Mehta SJ, Feingold J, Vandertuyn M, et al. Active choice and financial incentives to increase rates of screening colonoscopy: A randomized controlled trial. Gastroenterology. 2017;153:1227-9.
42. Narula T, Ramprasad C, Ruggs EN, et al. Increasing colonoscopies? A psychological perspective on opting in versus opting out. Health Psychol. 2014;33:1426-9.
43. van Roon AH, Hol L, Wilschut JA, et al. Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial. Prev Med. 2011;52:448-51.
44. Cole SR, Smith A, Wilson C, et al. An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14:73-75.
45. Fehr E, Gachter S. Fairness and retaliation: The economics of reciprocity. J Econ Perspect. 2000;14:159-81.
46. Kahneman D, Knetsch JL, Thaler RH. Experimental tests of the endowment effect and the Coase theorem. J Political Econ. 1990;98:1325-48.
47. Keller PA, Harlam B, Loewenstein G, et al. Enhanced active choice: A new method to motivate behavior change. J Consum Psychol. 2011;21:376-83.
48. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88-100.
49. Lairson DR, Dicarlo M, Deshmuk AA, et al. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care. Cancer. 2014;120:1042-9.
50. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: A randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-82.